These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34349458)

  • 1. Evaluation of the confidential unit exclusion on Iranian blood donors: An 11-year experience.
    Ameli MR; Hosseini SH; Rad F; Sajjadi SM
    Asian J Transfus Sci; 2021; 15(1):57-61. PubMed ID: 34349458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 6 years of confidential unit exclusion at the Belgian Red Cross Flanders Blood Service.
    Vandewalle G; Baeten M; Bogaerts K; Vandekerckhove P; Compernolle V
    Vox Sang; 2014 May; 106(4):354-60. PubMed ID: 24289738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prevalence of major transfusion-transmitted infections among Iranian blood donors using confidential unit exclusion in an Iranian population: Transfusion-transmitted infections among Iranian blood donors.
    Omidkhoda A; Gharehbaghian A; Jamali M; Ahmadbeigi N; Hashemi SM; Rahimi A; Soleimani M
    Hepat Mon; 2011 Jan; 11(1):11-3. PubMed ID: 22087109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confidential unit exclusion (CUE): Double edged sword for blood transfusion center: A ten-year study on volunteer blood donors in Kohgiluyeh and Boyer Ahmad province, Iran.
    Rad F; Sajjadi SM; Azizi A; Maghsudlu M
    Transfus Clin Biol; 2019 Nov; 26(4):253-256. PubMed ID: 31174915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE policies in Brazil.
    de Almeida-Neto C; Liu J; Wright DJ; Mendrone-Junior A; Takecian PL; Sun Y; Ferreira JE; de Alencar Fischer Chamone D; Busch MP; Sabino EC;
    Transfusion; 2011 Jan; 51(1):191-7. PubMed ID: 20663108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of seromarkers for HIV, HBV and syphilis among blood donors using confidential unit exclusion, before and after HIV-NAT implementation at a major public blood bank in the Brazilian Amazon.
    Souza JC; Crispim MAE; Abrahim C; Fraiji NA; Kiesslich D; Stefani MMA
    Transfusion; 2019 Feb; 59(2):629-638. PubMed ID: 30499594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on confidential unit exclusion at Shiraz Blood Transfusion Center, Iran.
    Kasraian L; Karimi MH
    Asian J Transfus Sci; 2016; 10(2):132-5. PubMed ID: 27605850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience.
    O'Brien SF; Fan W; Xi G; Yi QL; Goldman M
    Vox Sang; 2010 Feb; 98(2):138-44. PubMed ID: 19754523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of the confidential unit exclusion option.
    Petersen LR; Lackritz E; Lewis WF; Smith DS; Herrera G; Raimondi V; Aberle-Grasse J; Dodd RY
    Transfusion; 1994 Oct; 34(10):865-9. PubMed ID: 7940657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-time Blood Donors Are Double-edged Swords for Blood Transfusion Centers: A Retrospective Study in Southwest Iran.
    Niazkar HR; Dorgalaleh A; Rad F
    Turk J Haematol; 2020 Feb; 37(1):30-35. PubMed ID: 31475800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics and serological profile of blood donors who opt for the confidential unit exclusion in a blood bank in Sao Paulo, Brazil.
    Delatorre MVV; Batalha KM; Santos LD; Bonet-Bub C; Avelino-Silva VI
    Rev Inst Med Trop Sao Paulo; 2021; 63():e69. PubMed ID: 34495266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study.
    Korelitz JJ; Williams AE; Busch MP; Zuck TF; Ownby HE; Matijas LJ; Wright DJ
    Transfusion; 1994 Oct; 34(10):870-6. PubMed ID: 7940658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State.
    Vogler IH; Saito M; Spinosa AA; da Silva MC; Munhoz E; Reiche EM
    Rev Bras Hematol Hemoter; 2011; 33(5):347-52. PubMed ID: 23049338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sero-prevalence of transfusion transmittable infections: HIV, Hepatitis B, C and Treponema pallidum and associated factors among blood donors in Ethiopia: A retrospective study.
    Abdella S; Moshago Berheto T; Tolera G; Belete W; Deressa T; Feleke A; H/Silassie A; Gezahegn N; Tadesse D; Tefera M; Dillnessa E; Kinfu A; Abate E; Kifle T
    PLoS One; 2020; 15(10):e0241086. PubMed ID: 33119668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current impact of the confidential unit exclusion option.
    Zou S; Notari EP; Musavi F; Dodd RY;
    Transfusion; 2004 May; 44(5):651-7. PubMed ID: 15104644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of information technology may increase the efficacy of Confidential Unit Exclusion (CUE) in blood donors.
    Jalalian M; Mahboobi H
    Electron Physician; 2013; 5(2):651-3. PubMed ID: 26120398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the confidential unit exclusion option in blood donors in tehran, iran, determined by using the nucleic Acid testing method in 2008 and 2009.
    Farhadi E; Gharehbaghian A; Karimi G; Samiee S; Tavasolli F; Salimi Y
    Hepat Mon; 2011 Nov; 11(11):907-12. PubMed ID: 22308155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and trends in transfusion-transmissible infections among blood donors in Brazil from 2010 to 2016.
    Pessoni LL; Aquino ÉC; Alcântara KC
    Hematol Transfus Cell Ther; 2019; 41(4):310-315. PubMed ID: 31409582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.